Compare iShares MSCI South Africa ETF (EZA) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI South Africa ETF vs Hims and Hers Health Inc — how do they compare? iShares MSCI South Africa ETF trades at $63.8 (market cap $455.34M), while Hims and Hers Health Inc trades at $30.92 (market cap $6.55B). The key difference: Hims and Hers Health Inc is far larger — about 14.4× iShares MSCI South Africa ETF's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, iShares MSCI South Africa ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI South Africa ETF for 70 Days and Hims and Hers Health Inc for 21 Days on average.
| EZA | HIMS | |
|---|---|---|
Market Cap | $455.34M | $6.55B |
Volume | 148,692 | 14,842,814 |
Sector | Broad Market / Factor | Health |
52-Week High | $81.60 | $62.76 |
52-Week Low | $60.43 | $14.52 |
Typical Hold Time | 70 Days | 21 Days |
Enterprise Value | — | $7.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EZA trades at $63.8, up 2.42% today, but technical indicators signal a bearish trend with moving averages and oscillators in sell territory. The stock faces resistance near $64 and support at $61. Recent news highlights a brief price surge above the 50-day moving average in September but ongoing macroeconomic pressures from South Africa's exposure to commodities and financials.
The outlook remains cautious due to global reflation and high capital costs weighing on EZA's holdings. Risks include commodity price volatility and interest rate sensitivity, while potential upside hinges on stabilization in South African markets. Investors should weigh the ETF's concentrated exposures against broader emerging market uncertainties.
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares MSCI South Africa ETF
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
